OBI Pharma, Inc. (4174.TWO) has a MoatMap StockRank of 3/100 based on Quality (24/100), Value (36/100), and Momentum (20/100) factor scores. The current signal is STRONG SELL. Healthcare sector in Taiwan does not present an asymmetric opportunity from the current macro themes. The 'STRONG_SELL' signal and low quality score indicate it fails the fund's rigorous quality and risk-reward criteria.